Horizon Kinetics Medical ETF Rating $27.72 -0.33 (-1.18%) Closing price 07/11/2025 03:55 PM EasternExtended Trading$27.72 +0.00 (+0.00%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.65Holdings in MEDX have an aggregate rating of Moderate Buy based on 368 analyst ratings issued in the past year covering 23 companies (84.4% of the portfolio).MEDX Aggregate Price Target$27.72High Prediction$27.72Average Prediction$27.72Low Prediction$27.72Holdings in MEDX have an aggregate price target of $27.72 and a range of $27.72 to $27.72 covering 23 companies (84.4% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.06%LLYEli Lilly and Company$793.34+0.3%4.9813 of 5 stars2.75$1,012.56 27.6%20Trending NewsAnalyst ForecastAnalyst Revision8.91%ABBVAbbVie$192.32-1.4%4.5022 of 5 stars2.81$211.29 9.9%27Trending NewsAnalyst Revision6.09%AMGNAmgen$295.27-1.7%4.4353 of 5 stars2.35$307.82 4.2%23Positive NewsAnalyst Revision5.77%ALNYAlnylam Pharmaceuticals$314.94-2.4%4.1824 of 5 stars2.80$345.70 9.8%25Positive NewsAnalyst Forecast5.37%AZNAstraZeneca$71.13-0.9%3.7594 of 5 stars2.83$89.00 25.1%6Positive NewsAnalyst Forecast5.11%BMYBristol Myers Squibb$46.91-3.3%4.8897 of 5 stars2.32$57.69 23.0%22Trending NewsAnalyst ForecastAnalyst Revision4.81%JNJJohnson & Johnson$156.87-0.5%4.8126 of 5 stars2.55$171.00 9.0%20Trending NewsUpcoming EarningsAnalyst Forecast4.16%ALKSAlkermes$30.28-0.6%4.7999 of 5 stars2.83$40.00 32.1%12Positive News4.05%PFEPfizer$25.65-0.5%4.9708 of 5 stars2.45$28.55 11.3%22Trending NewsAnalyst Revision3.36%MRKMerck & Co., Inc.$83.35-0.8%4.9925 of 5 stars2.43$108.69 30.4%21Trending NewsAnalyst ForecastAnalyst Revision3.34%CRSPCRISPR Therapeutics$56.80-3.7%3.2427 of 5 stars2.53$71.75 26.3%17News CoverageAnalyst ForecastOptions Volume3.22%IONSIonis Pharmaceuticals$41.73-1.5%4.6042 of 5 stars2.78$58.25 39.6%18Positive News2.66%GSKGSK$38.29-3.3%1.7905 of 5 stars2.11$37.38 -2.4%9Gap Down2.51%BIIBBiogen$134.21-0.8%4.7789 of 5 stars2.38$188.48 40.4%32Trending NewsAnalyst Revision2.40%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8321 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision1.14%BEAMBeam Therapeutics$21.16-3.9%2.0931 of 5 stars3.00$48.75 130.4%15News Coverage0.91%NTLAIntellia Therapeutics$11.53-5.2%4.3519 of 5 stars2.65$33.37 189.4%200.88%HLNHaleon$9.96-1.5%3.5633 of 5 stars2.73$12.33 23.7%11News CoverageAnalyst Downgrade0.86%REPLReplimune Group$10.97+1.9%4.0717 of 5 stars3.13$20.83 89.9%8News CoverageHigh Trading Volume0.78%VNDAVanda Pharmaceuticals$4.74-5.0%4.7251 of 5 stars3.50$16.50 248.1%20.71%GALTGalectin Therapeutics$2.51+2.4%2.1058 of 5 stars3.00$6.00 139.0%1News CoveragePositive News0.65%SDZNYSandoz Group$55.94-0.1%1.6904 of 5 stars2.0020.64%BCYCBicycle Therapeutics$8.00-1.1%3.7238 of 5 stars2.70$25.00 212.5%10News Coverage This page (NASDAQ:MEDX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
